[SOX5: A core transcription factor from development to multi-system disease regulation].
1/5 보강
SOX5, as an important member of the SOX transcription factor family, is widely involved in various physiological and pathological processes.
APA
Hu GX, Yang Y, et al. (2025). [SOX5: A core transcription factor from development to multi-system disease regulation].. Sheng li xue bao : [Acta physiologica Sinica], 77(6), 1009-1022. https://doi.org/10.13294/j.aps.2025.0080
MLA
Hu GX, et al.. "[SOX5: A core transcription factor from development to multi-system disease regulation].." Sheng li xue bao : [Acta physiologica Sinica], vol. 77, no. 6, 2025, pp. 1009-1022.
PMID
41423973 ↗
Abstract 한글 요약
SOX5, as an important member of the SOX transcription factor family, is widely involved in various physiological and pathological processes. SOX5 regulates the expression of key genes involved in cell differentiation, proliferation, and development by interacting with specific DNA sequences through its HMG-box DNA-binding domain. SOX5 plays a critical role in cartilage development; it has a key regulatory effect on neuronal migration and differentiation in the nervous system; and it influences gonad development and spermatogenesis in the reproductive system. In terms of diseases, defects in SOX5 are closely associated with Lamb-Shaffer syndrome, type 2 diabetes, and respiratory system diseases. Furthermore, SOX5 plays a role in cancer progression by modulating various signaling pathways to promote or inhibit the proliferation and migration of different types of cancer cells. This review summarizes the physiological and pathological mechanisms of SOX5 in multiple systems and explores its potential as a therapeutic target for disease treatment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.